ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.150
-0.050 (-4.17%)
At close: Jul 24, 2026, 4:00 PM EDT
1.155
+0.005 (0.43%)
After-hours: Jul 24, 2026, 7:34 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $29.06 million as of July 24, 2026. Its market cap has decreased by -43.57% in one year.
Market Cap
29.06M
Enterprise Value
31.59M
1-Year Change
-43.57%
Ranking
Category
Stock Price
$1.15
ChartMarket Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $29.06M, a decrease of -63.45%. That is a compound annual growth rate of -18.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 29.90M | -42.28% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 34.97M |
| Lite Strategy | 34.03M |
| Estrella Immunopharma | 33.57M |
| BriaCell Therapeutics | 31.87M |
| Serina Therapeutics | 31.49M |
| VYNE Therapeutics | 29.76M |
| Actuate Therapeutics | 29.55M |
| Aligos Therapeutics | 28.96M |